Pietro Pantaleo

688 total citations
20 papers, 469 citations indexed

About

Pietro Pantaleo is a scholar working on Oncology, Hepatology and Molecular Biology. According to data from OpenAlex, Pietro Pantaleo has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Pietro Pantaleo's work include Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Pietro Pantaleo is often cited by papers focused on Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Pietro Pantaleo collaborates with scholars based in Italy, United States and Spain. Pietro Pantaleo's co-authors include Paolo Geñtilini, Vinicio Carloni, Giacomo Laffi, Antonio Mazzocca, Francesco Vizzutti, Giorgio La Villa, Roberto Mazzanti, Ornella Fantappiè, Giuseppe Barletta and Michela Solazzo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Clinical Cancer Research.

In The Last Decade

Pietro Pantaleo

20 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pietro Pantaleo Italy 13 164 152 118 113 87 20 469
Françoise Gellibert France 8 462 2.8× 69 0.5× 157 1.3× 62 0.5× 61 0.7× 8 730
M Mise Japan 8 298 1.8× 206 1.4× 140 1.2× 56 0.5× 56 0.6× 12 560
Danièle Delautier France 12 117 0.7× 54 0.4× 154 1.3× 75 0.7× 151 1.7× 16 423
F. Mihaimeed United Kingdom 5 332 2.0× 69 0.5× 91 0.8× 53 0.5× 63 0.7× 6 529
S. Theocharis Greece 10 314 1.9× 48 0.3× 97 0.8× 56 0.5× 62 0.7× 16 551
Aastha Jindal Italy 5 203 1.2× 173 1.1× 71 0.6× 336 3.0× 57 0.7× 8 627
Hisato Maekawa Japan 10 293 1.8× 155 1.0× 36 0.3× 129 1.1× 84 1.0× 19 570
Yan Yao China 10 179 1.1× 136 0.9× 75 0.6× 46 0.4× 42 0.5× 20 352
Yutaka Yamanaka Japan 14 334 2.0× 89 0.6× 113 1.0× 111 1.0× 48 0.6× 27 539

Countries citing papers authored by Pietro Pantaleo

Since Specialization
Citations

This map shows the geographic impact of Pietro Pantaleo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Pantaleo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Pantaleo more than expected).

Fields of papers citing papers by Pietro Pantaleo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Pantaleo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Pantaleo. The network helps show where Pietro Pantaleo may publish in the future.

Co-authorship network of co-authors of Pietro Pantaleo

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Pantaleo. A scholar is included among the top collaborators of Pietro Pantaleo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Pantaleo. Pietro Pantaleo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padeletti, Luigi, Pietro Amedeo Modesti, Giuseppe Ricciardi, et al.. (2014). Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure. Journal of Cardiovascular Medicine. 15(4). 295–300. 11 indexed citations
2.
Neri, B, Gianluca Cipriani, Pietro Pantaleo, et al.. (2009). Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(11). 559–564. 10 indexed citations
3.
Neri, B, et al.. (2009). Weekly Administration of Docetaxel and Epirubicin as First-Line Treatment for Hormone-Refractory Prostate Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(11). 565–570. 4 indexed citations
4.
Neri, B, Pietro Pantaleo, Elisa Giommoni, et al.. (2007). Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. British Journal of Cancer. 96(7). 1043–1046. 14 indexed citations
5.
Pantaleo, Pietro, et al.. (2007). Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study. Anti-Cancer Drugs. 18(10). 1207–1211. 9 indexed citations
6.
Neri, B, Lorenzo Vannozzi, Pietro Pantaleo, et al.. (2006). Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study. Cancer Investigation. 24(5). 474–478. 8 indexed citations
7.
Mazzanti, Roberto, Michela Solazzo, Ornella Fantappiè, et al.. (2006). Differential expression proteomics of human colon cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(6). G1329–G1338. 62 indexed citations
9.
Carloni, Vinicio, Francesco Vizzutti, & Pietro Pantaleo. (2005). Farnesyltransferase Inhibitor, ABT-100, Is a Potent Liver Cancer Chemopreventive Agent. Clinical Cancer Research. 11(11). 4266–4274. 16 indexed citations
10.
Fantappiè, Ornella, Maura Lodovici, Paola Fabrizio, et al.. (2004). Vitamin E Protects DNA from Oxidative Damage in Human Hepatocellular Carcinoma Cell Lines. Free Radical Research. 38(7). 751–759. 25 indexed citations
11.
Pantaleo, Pietro, Fabio Marra, Francesco Vizzutti, et al.. (2004). Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. Clinical Science. 106(1). 27–34. 17 indexed citations
12.
Mazzanti, Roberto, Enrico Mini, Stefania Nobili, et al.. (2004). Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study. Digestive and Liver Disease. 36(4). 278–285. 8 indexed citations
13.
Mazzanti, Roberto, Umberto Arena, Pietro Pantaleo, et al.. (2004). Survival and Prognostic Factors in Patients with Hepatocellular Carcinoma Treated by Percutaneous Ethanol Injection: A 10-Year Experience. SHILAP Revista de lepidopterología. 18(10). 611–618. 12 indexed citations
14.
15.
Mazzocca, Antonio, Vinicio Carloni, Pietro Pantaleo, et al.. (2002). Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. Journal of Hepatology. 37(3). 322–330. 53 indexed citations
16.
Villa, Giorgio La, Giuseppe Barletta, Roberto Giulio Romanelli, et al.. (2002). Cardiovascular effects of canrenone in patients with preascitic cirrhosis. Hepatology. 35(6). 1441–1448. 20 indexed citations
17.
Villa, Giulia, Giuseppe Barletta, D. Righi, et al.. (2002). Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. Digestive and Liver Disease. 34(10). 717–722. 1 indexed citations
18.
Lagi, Alfonso, Giacomo Laffi, Simone Cencetti, et al.. (2002). Impaired sympathetic regulation of cerebral blood flow in patients with cirrhosis of the liver. Clinical Science. 103(1). 43–51. 16 indexed citations
19.
Villa, Giorgio La, Giuseppe Barletta, Pietro Pantaleo, et al.. (2001). Hemodynamic, Renal, and Endocrine Effects of Acute Inhibition of Nitric Oxide Synthase in Compensated Cirrhosis. Hepatology. 34(1). 19–27. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026